Sign inLaunch App
BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·BTC——·ETH——·GOLD——·NVDA——·SPCX——·SP500——·CC——·
RIVUS PHARMACEUTICALS
Rivus Pharmaceuticals
Biotechnology/Pharmaceuticals · Charlottesville, Virginia · United States · Founded · 2006 · ≈ · 80 · employees

Rivus Pharmaceuticals competitors

Private

Rivus Pharmaceuticals has 6 close competitors: Atomwise, BioMason, Colossal Biosciences.

ProfileValuationFundingCompetitorsStock & IPOHow to invest
Peer set

Who competes with Rivus Pharmaceuticals

Sector, valuation and status for each competitor.

company profileRivus Pharmaceuticals›
Founded 2006United States
competitorAtomwise›
$320Mlatest valuation
Founded 2012Private
competitorBioMason›
Founded 2012Private
competitorColossal Biosciences›
$25Bas of Jul 2026
Founded 2021Private
competitorEcovativa Design›
$130Mas of Dec 2025
Founded 2007Private
competitorFormation Bio›
$1.7Bas of Jun 2024
Founded 2016Private
competitorHalda Therapeutics›
$250Mlatest valuation
Head-to-head

Rivus Pharmaceuticals and its peers, side by side

A private valuation and a public market cap share one column; each row names its basis and date.

Company
Sector
Founded
Valuation / market cap
Status
HQ
On Canborsa
Rivus Pharmaceuticals
Biotechnology/Pharmaceuticals
2006
no figure
PRIVATE
United States
Company profile
Atomwise
Biotechnology / AI drug discovery
2012
$320M
PRIVATE
United States
Company profile
BioMason
Biotechnology
2012
no figure
PRIVATE
United States
Company profile
Colossal Biosciences
Biotechnology
2021
$25Brumored · Jul 2026
PRIVATE
United States
Company profile
Ecovativa Design
Biotechnology / Materials
2007
$130MDec 2025
PRIVATE
United States
Company profile
Formation Bio
Biotechnology / Drug discovery
2016
$1.7BJun 2024
PRIVATE
United States
Company profile
HTHalda Therapeutics
Biotechnology
$250M
PRIVATE
United States
Company profile
Context · reading the peer set

Where Rivus Pharmaceuticals meets its rivals

What Rivus Pharmaceuticals sells, and where the rivals meet it

Pharmaceutical company developing oral medicines for cardiometabolic health and metabolic dysfunction-associated steatohepatitis (MASH), with lead therapy HU6 and secondary candidate RV-8451.

Rivus Pharmaceuticals competes with 6 companies here: Atomwise, BioMason, Colossal Biosciences, Ecovativa Design, Formation Bio, Halda Therapeutics.

Rivus Pharmaceuticals on Canborsa
MarketClosest: SP500-PERP
Fees0.07% per side · 0.14% round-trip
Fundingevery 1h

Rivus Pharmaceuticals competitors — frequently asked questions

How can I get exposure to Rivus Pharmaceuticals?›

The routes section explains what is realistically available for a company at this stage.

Is Rivus Pharmaceuticals publicly traded?›

No. Rivus Pharmaceuticals is a private company; its shares do not trade on a public exchange.

Who are Rivus Pharmaceuticals's competitors?›

The closest biotechnology/pharmaceuticals peers are on the competitors page.

Keep exploring
More in Biotechnology
Vivex Biologics competitorscompetitors›Orbital Therapeutics profilecompany · profile›Colossal Biosciences funding historyfunding›Life Biosciences profilecompany · profile›All companiesdirectory›
Learn
Stock perps vs tokenized stocksconcept›RWA perpetualsmarkets · index›Perpetuals vs futuresconcept›What is a perpetual?guide · perpetuals basics›All Learn guideslearn · index›
Listed on Canborsa
Cerebras Systems (CBRS)US equity · perp›ChangXin Memory Technologies (CXMT)Asian equity · perp›SpaceX (SPCX)US equity · perp›Tesla (TSLA)US equity · perp›All 86 marketsindex›
Index · Perpetual · 30x

Trade SP500-PERP on Canborsa

S&P 500 · the Canborsa market closest to Rivus Pharmaceuticals
SpaceXAnthropicROM TechnologiesReserveOneRunPodAll companies ›
© Canborsa 2026TermsPrivacy